Navigation Links
Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials
Date:7/17/2008

, with minimal impact on normal brain tissue. During the course of development at Duke University, over US$60 million in research grants and related support has produced a series of Phase I and Phase II clinical trials on Neuradiab(TM) and other closely related technologies. Approximately 200 brain cancer patients, including over 160 with GBM, have been treated with the Neuradiab therapy regimen, and survival benefits have significantly exceeded historical controls in each completed trial. Neuradiab(TM) has been formerly referred to in literature as 131I anti-tenascin monoclonal antibody 81c6.

Each year up to 30,000 new cases of GBM are diagnosed in the world's seven largest healthcare markets. The current standard of care for GBM patients is surgical resection followed by radiation and temozolomide. GBM tumors typically have infiltrating edges that are very difficult to completely remove with surgery. The Neuradiab(TM) therapy is delivered directly into the surgical resection cavity in a separate procedure after the initial surgery. Neuradiab(TM) delivers a concentrated level of radiation specifically to the remaining cancer cells by targeting tenascin. Tenascin is a protein over-expressed in 99% of GBM cells but absent from normal brain cells.

About Bradmer Pharmaceuticals Inc. (http://www.bradmerpharma.com)

Bradmer Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of new and innovative cancer therapies. Bradmer's lead clinical candidate, Neuradiab, was developed at Duke University Medical Center as a proprietary therapy for a particularly aggressive form of brain cancer, glioblastoma multiforme. Prior to the Company's inception, over US$60 million in grants and related support had driven research and development of the licensed treatment, which has been delivered to over 200 patients with promising results in Phase I and Phase II clinical tr
'/>"/>

SOURCE Bradmer Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. GeoVax Reports Progress on Its AIDS Vaccine Technology
2. Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer
3. MAP Pharmaceuticals Reports Positive Pharmacological Response Data for Migraine Product Candidate at the American Headache Society Annual Meeting
4. Alimera Reports Results From the Three-Month Interim Readout of the Human PK Medidur(TM) FA Study
5. Ardea Biosciences Reports Additional Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating Up to 1.9 Log Reduction in Plasma Viral Load with Once-Daily Dosing
6. Victory Pharma, Inc. Reports MGX006 Enters Into Pivotal Development Program
7. Human Genome Sciences Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus
8. Synvista Therapeutics Reports Results of Three Phase 2 Clinical Trials of SYI-2074 in Diabetic Patients with Cardiovascular Disease
9. Genetic Engineering & Biotechnology News Reports on the Growing Role of Ion-Channel Studies in Global Biotech R&D
10. Semafore Pharmaceuticals Reports Positive Interim Results from a Phase I Study of SF1126, a Targeted Pan-PI3K Inhibitor, in Patients with Advanced Solid Tumors
11. Valor Medical Reports Early Clinical Results of New Technology to Treat Cerebral Aneurysms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... -- Five MinuteClinic walk-in medical clinics are opening inside select CVS/pharmacy ... clinics opened in Memphis and ... added in Springfield on September 24 and ... to open October 22.  MinuteClinic is the largest and fastest growing ... . The Memphis -area clinics ...
(Date:9/19/2014)... 19, 2014 According to ... (Benchtop, Mobile, Industrial, & Laboratory), Industry (Food, Pharmaceutical, ... & Rotary) & Geography - Global Trends & ... segments the lyophilization market on the basis of ... projections of the market size of each of ...
(Date:9/19/2014)... , Sept. 19, 2014  Pressure BioSciences, ... announced it has received and approved all parts ... instruments and has begun to manufacture the new ... instrument will be ready for shipment by mid-October ... and released at a rate of about one ...
Breaking Medicine Technology:MinuteClinic Walk-in Medical Clinics Opening in Memphis 2MinuteClinic Walk-in Medical Clinics Opening in Memphis 3Lyophilization Market Worth $5,121.5 Million by 2019 2Lyophilization Market Worth $5,121.5 Million by 2019 3Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 2Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 3
... BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) today ... will present a company update at the Morgan Stanley Global ... at 10:55 a.m. ET.   Interested parties may ... the investor section of the BioMarin website, www.BMRN.com . ...
... Sept. 7, 2011 Generex Biotechnology Corporation ( ... Fletcher, the Company,s President & Chief Executive Officer, ... Company,s wholly-owned subsidiary, Antigen Express, Inc. ( www.antigenexpress.com ... Rodman & Renshaw 13th Annual Healthcare Conference.  The ...
Cached Medicine Technology:BioMarin to Present at the Morgan Stanley Global Healthcare Conference 2Generex to Present at the Rodman & Renshaw 13th Annual Healthcare Conference 2Generex to Present at the Rodman & Renshaw 13th Annual Healthcare Conference 3
(Date:9/21/2014)... September 22, 2014 UNIWIGS, one of the ... extensions and hair pieces, offers a line of human hair ... trend and it also shows people what the latest ... famous star Rihanna, there are 4 different hairstyles to choose ... of ombre wave lace wigs and a hot ombre red ...
(Date:9/21/2014)... 21, 2014 Hastings and Hastings, a ... record demand for aggressively discounted accident victim attorney’s fees. ... the Valley each year, it is more important than ... discounted attorney’s fees as a way to enjoy more ... has been a frontrunner when it comes to delivering ...
(Date:9/21/2014)... (PRWEB) September 21, 2014 More than a quarter ... most dryer fires start in one of two ways. The ... cleaned out properly. The second type of dryer fire occurs ... (Dryers can also catch fire due to malfunctioning electrical systems ... repairman to take a look!) Here are some ways that ...
(Date:9/21/2014)... roasted peanuts are more likely to trigger an allergy ... study involving mice. , The researchers say that specific ... dry roasting process are recognised by the body,s immune ... immune response the next time it sees any peanuts. ... number of people with peanut allergies in the Western ...
(Date:9/21/2014)... 2014 Expert witness work is in! ... from its 2014 Expert Witness Fees & Practices Survey. ... demand and compensation for qualified and credentialed expert witnesses ... 16-year history. , The nearly 600 experts surveyed ... expert work, an increase of 3.2% from ExpertPages’ 2012 ...
Breaking Medicine News(10 mins):Health News:UniWigs New Arrivals Just In- Human Hair Lace Wigs Inspired By Famous Celebrities 2Health News:Hastings & Hastings Announces Record Demand For Aggressively Discounted Accident Victim Attorney’s Fees 2Health News:Hastings & Hastings Announces Record Demand For Aggressively Discounted Accident Victim Attorney’s Fees 3Health News:Restoration Local Offers Tips to Avoid Dryer Fires 2Health News:Restoration Local Offers Tips to Avoid Dryer Fires 3Health News:Dry roasting could help trigger peanut allergy 2Health News:ExpertPages 2014 Survey Reports Expert Witness Hourly Fees Record All-Time Highs as Demand for Qualified Experts Continues to Grow 2
... (HealthDay News) -- Vigorous exercise offers more of a ... finds. U.K. researchers compared 11 sedentary people who ... before, during, immediately following, and 20 minutes after they ... negative during and immediately after high-intensity exercise, compared to ...
... (HealthDay News) -- Breast shields are the best way to protect ... chest CT examination, according to a new study. The researchers ... partial CT, in which the CT scanner turns on and off ... at Penn State Hershey Medical Center measured the radiation dose to ...
... with congestive heart failure who repress their emotions, especially ... experience symptoms of depression associated with knowledge about their ... women in the study influenced how depressed or anxious ... their emotions, the more likely they were to have ...
... Sustainable, comprehensive and problem-based training to prevent child obesity ... five-year grant from the U.S. Department of Agriculture. ... last 30 years. Obesity now affects nearly one in ... Penn State,s Childhood Obesity Prevention Graduate Training Program, a ...
... MR arthrography for diagnosing glenoid rim osseous lesions, lesions that ... surgery, according to a new study. The ... included 40 patients scheduled for shoulder surgery. All patients ... exam (the current standard exam). "Our study found that MDCTA ...
... TUESDAY, May 3 (HealthDay News) -- The U.S. Food ... are cracking down on manufacturers of over-the-counter products that ... The agencies jointly sent letters to companies including ... that their products are unproven and violate federal law, ...
Cached Medicine News:Health News:More knowledge not always helpful for women dealing with heart disease 2Health News:More knowledge not always helpful for women dealing with heart disease 3Health News:More knowledge not always helpful for women dealing with heart disease 4Health News:U.S. Officials Take Aim at Questionable STD Products 2
... Standard snap ring receiver ... nursing., ,Impressions of your ... ,Westone custom products for the ... worldwide network of hearing healthcare ...
... fibre bronchoscopy: The HF-compatible V series from ... fibre bronchoscopes are measured., ,The HF-compatible ... the FB-19TV, FB-18V and FB-15V models along ... pediatric FB-8V, offer much better image quality ...
... fibre bronchoscopy: The HF-compatible V series from ... fibre bronchoscopes are measured., ,The HF-compatible ... the FB-19TV, FB-18V and FB-15V models along ... pediatric FB-8V, offer much better image quality ...
... therapeutic fiberoptic bronchoscopes offers ... channel with a slim ... channel allows for improved ... of cytology brushes. The ...
Medicine Products: